International multicenter RCT aimed to reduce HF readmissions and mortality events within a 30-day period following patient discharge by implementation of ReDS-guided treatment during hospitalization and at the post-discharge follow-up clinic. The trial demonstrated a significant reduction in HF readmissions and mortality events with a hazard ratio (HR) of 0.094 (95% CI 0.012-0.731)
Use of ReDS POC testing at a post-discharge outpatient clinic for optimization of GDMT medications resulted in a 79% decrease in 30-day CV readmission rate. Real world data of 220 patients from Mount Sinai hospital
Reviews ReDS technology (and CardioMEMS) for providing accurate, absolute, and actionable congestion measurement and guiding patients management in various settings across the continuum of care